673-06-3 | D-Phenylalanine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$12.00	$8.00
5g	98%	in stock	$13.00	$9.00
25g	98%	in stock	$19.00	$13.00
100g	98%	in stock	$26.00	$18.00
500g	98%	in stock	$109.00	$76.00

Description

• Catalog Number: AB46002
• Chemical Name: D-Phenylalanine
• CAS Number: 673-06-3
• Molecular Formula: C9H11NO2
• Molecular Weight: 165.1891
• MDL Number: MFCD00004270
• SMILES: N[C@@H](C(=O)O)Cc1ccccc1
• NSC Number: 758460

Computed Properties

• Complexity: 153
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• XLogP3: -1.5

Upstream Synthesis Route

(R)-2-Amino-3-phenylpropionic acid, also known as phenylalanine, plays a crucial role in chemical synthesis as a chiral building block. With its unique structural features, this compound is widely utilized in the production of pharmaceuticals, flavors, and fragrances. In organic synthesis, (R)-2-Amino-3-phenylpropionic acid serves as a key starting material for the preparation of various chiral compounds and complex molecules.Its chiral nature makes it a valuable tool for creating stereochemically pure compounds, which are essential in the development of new drugs and advanced materials. By incorporating (R)-2-Amino-3-phenylpropionic acid into chemical reactions, chemists can selectively control the stereochemistry of the resulting products, enabling the synthesis of enantiomerically pure compounds with enhanced biological activity and specificity.Furthermore, (R)-2-Amino-3-phenylpropionic acid acts as a versatile intermediate in the asymmetric synthesis of amino acids, peptides, and other biologically active molecules. Its presence in a molecule can significantly influence its properties and interactions, making it a valuable component in the design and optimization of pharmaceuticals and bioactive compounds.Overall, the versatile applications of (R)-2-Amino-3-phenylpropionic acid in chemical synthesis highlight its importance as a valuable building block for creating diverse and complex compounds with specific stereochemical properties and biological activities.

Literature

• Chromium (D-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities.

  Journal of inorganic biochemistry 20110101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• The effect of immobilization of thrombin inhibitors onto self-assembled monolayers on the adsorption and activity of thrombin.

  Biomaterials 20100501

• Carbonic anhydrase activators. The first activation study of a coral secretory isoform with amino acids and amines.

  Bioorganic & medicinal chemistry 20100315

• Carbonic anhydrase activators: Activation of the beta-carbonic anhydrase from the pathogenic yeast Candida glabrata with amines and amino acids.

  Bioorganic & medicinal chemistry letters 20100301

• Carbonic anhydrase activators: activation of the beta-carbonic anhydrases from the pathogenic fungi Candida albicans and Cryptococcus neoformans with amines and amino acids.

  Bioorganic & medicinal chemistry 20100201

• Salivary gland derived peptides as a new class of anti-inflammatory agents: review of preclinical pharmacology of C-terminal peptides of SMR1 protein.

  Journal of inflammation (London, England) 20100101

• Enantioselective binding of L,D-phenylalanine to ct DNA.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091015

• Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.

  European journal of medicinal chemistry 20091001

• Carbonic anhydrase activators. Activation of the membrane-associated isoform XV with amino acids and amines.

  Bioorganic & medicinal chemistry letters 20090701

• Carbonic anhydrase activators: activation of the beta-carbonic anhydrase Nce103 from the yeast Saccharomyces cerevisiae with amines and amino acids.

  Bioorganic & medicinal chemistry letters 20090315

• Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B.

  Proceedings of the National Academy of Sciences of the United States of America 20090310

• Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.

  European journal of medicinal chemistry 20090101

• Carbonic anhydrase activators: activation of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases with amino acids and amines.

  Bioorganic & medicinal chemistry letters 20081201

• Carbonic anhydrase activators: Activation of the human cytosolic isozyme III and membrane-associated isoform IV with amino acids and amines.

  Bioorganic & medicinal chemistry letters 20080801

• Acupuncture anesthesia and analgesia for clinical acute pain in Japan.

  Evidence-based complementary and alternative medicine : eCAM 20080601

• Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines.

  Bioorganic & medicinal chemistry 20080401

• The tripeptide feG inhibits leukocyte adhesion.

  Journal of inflammation (London, England) 20080101

• Production of enantiomerically pure (S)-beta-phenylalanine and (R)-beta-phenylalanine by penicillin G acylase from Escherichia coli in aqueous medium.

  Biotechnology letters 20071201

• Carbonic anhydrase activators: the first activation study of the human secretory isoform VI with amino acids and amines.

  Bioorganic & medicinal chemistry 20070801

• Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines.

  Bioorganic & medicinal chemistry letters 20070801

• Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.

  Bioorganic & medicinal chemistry letters 20070401

• Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines.

  Bioorganic & medicinal chemistry letters 20070301

• Microbial production of optically active beta-phenylalanine through stereoselective degradation of racemic beta-phenylalanine.

  Bioscience, biotechnology, and biochemistry 20060801

• Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.

  Journal of medicinal chemistry 20060518

• The tripeptide feG regulates the production of intracellular reactive oxygen species by neutrophils.

  Journal of inflammation (London, England) 20060101

• The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location.

  Genomics 20020101

• Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.

  Biochimica et biophysica acta 20011001

• Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.

  The Journal of biological chemistry 20010518

• Binding of D-phenylalanine and D-tyrosine to carboxypeptidase A.

  The Journal of biological chemistry 19890805